Published
Following our session, Has Guideline-Directed Medical Therapy Eliminated Sudden Cardiac Death Risk?, we’re sharing responses to the questions submitted during the live discussion. In this Q&A, we address residual arrhythmic risk in contemporary HFrEF care, real-world ICD therapy data, and practical workflow considerations.
- Categoria
- Cardiology
Commenta per primo questo video.
Prossimo
-
07:03
Q/A - Has GDMT Eliminated Sudden Cardiac Death Risk?
-
06:08
Multimorbidity and the Risk of Sudden Cardiac Death
-
06:38
Rocket Pharma's RP-A601: Gene Therapy Targeting Sudden Cardiac Death from PKP2-ACM
-
06:46
Mystery Behind Yoga Guru's Sudden Death From Heart Attack | Experts' View | Care Well Medical Centre
-
07:32
Breaking the Silence on Sudden Cardiac Death: Prevention, Risk, and the Science of Heart Resilience
-
13:46
Heart Failure Guideline-Directed Medical Therapy: Could Pharmacists Be the Fifth Pillar?
-
09:19
Brugada Syndrome ECG Explained | Type 1, Type 2, Type 3 Patterns & Sudden Cardiac Death
-
15:19
4 ECG Patterns that predict sudden Death
-
07:32
Breaking the Silence on Sudden Cardiac Death: Prevention, Risk, and the Science of Heart Resilience
-
04:50
Sudden Cardiac Death and HCM
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
